Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lesch

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Neuroscience Letters|April 15, 1999
Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporterA Rioux, V Fabre, K P Lesch, et al.
International Journal of Obesity (2005)|January 20, 2010
Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesityN Uçeyler, M Schütt, F Palm, et al.
Journal of Invertebrate Pathology|July 26, 2011
Requirements for baculoviruses for clinical gene therapy applicationsHanna P Lesch, Kaisa-Emilia Makkonen, Anna Laitinen, et al.
Journal of Neuroscience Research|February 14, 2003
Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient miceA Schmitt, R Mössner, A Gossmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
Cloning and functional characterization of the human norepinephrine transporter gene promoterJ Meyer, P Wiedemann, O Okladnova, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 29, 2000
hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophreniaG Stöber, J Meyer, I Nanda, et al.
American Journal of Medical Genetics|April 17, 2001
Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disordersY V Syagailo, G Stöber, M Grässle, et al.
Human Gene Therapy|February 21, 2020
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector ProductionHanna M Leinonen, Saana Lepola, Eevi M Lipponen, et al.
Current Gene Therapy|October 7, 2017
Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the EyesGiedrius Kalesnykas, Emmi Kokki, Laura Alasaarela, et al.
Gene Therapy|January 19, 2018
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactorA J Valkama, H M Leinonen, E M Lipponen, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Neuroscience Letters|April 15, 1999
Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporterA Rioux, V Fabre, K P Lesch, et al.
International Journal of Obesity (2005)|January 20, 2010
Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesityN Uçeyler, M Schütt, F Palm, et al.
Journal of Invertebrate Pathology|July 26, 2011
Requirements for baculoviruses for clinical gene therapy applicationsHanna P Lesch, Kaisa-Emilia Makkonen, Anna Laitinen, et al.
Journal of Neuroscience Research|February 14, 2003
Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient miceA Schmitt, R Mössner, A Gossmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
Cloning and functional characterization of the human norepinephrine transporter gene promoterJ Meyer, P Wiedemann, O Okladnova, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 29, 2000
hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophreniaG Stöber, J Meyer, I Nanda, et al.
American Journal of Medical Genetics|April 17, 2001
Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disordersY V Syagailo, G Stöber, M Grässle, et al.
Human Gene Therapy|February 21, 2020
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector ProductionHanna M Leinonen, Saana Lepola, Eevi M Lipponen, et al.
Current Gene Therapy|October 7, 2017
Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the EyesGiedrius Kalesnykas, Emmi Kokki, Laura Alasaarela, et al.
Gene Therapy|January 19, 2018
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactorA J Valkama, H M Leinonen, E M Lipponen, et al.
Pageof 29